The COVID-19 pandemic has gripped every nation's health care system and provisions on all levels. It is a respiratory disease which is caused by SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus-2). The first case of COVID-19 can be traced back to November, 2019 in China weeks before the authorities announced the emergence of the new virus.
The virus has affected all regions such as North America, Europe, Asia-Pacific, South America and Middle East and Africa. There is no region that is not affected by the virus. In March, the World Health Organization (WHO) declared COVID-19 as a pandemic referring to more than 118,000 cases of coronavirus disease in more than 110 countries and territories worldwide and the continuing possibility of further global spread.
While some countries have struggled to respond to the pandemic, others have faced the challenge far more effectively. The highest number of new confirmed cases globally was reported in December, 2020 (1,771,180). Countries such as the U.S., Brazil and Mexico were at the top with the highest death toll.
The pandemic has particularly impacted the field of thoracic surgery with elective (or cases which do not require immediate attention) operation being delayed while in some regions being halted. Certain clinical staffs have been asked to stay at home, there has been re-distribution of the clinical workforce to attend the COVID-19 patients causing disruption in normal public services affecting the healthcare workforce. As a result, the impact is noticeable in the thoracic surgery devices market.
Surgery on the organs in the chest or thorax requires thoracic surgery. The food pipe, wind pipe, lungs, chest wall, heart and diaphragm are among the most popular treatments. Thoracic surgery is frequently associated with heart surgery and is known as cardiothoracic surgery. The aim of thoracic surgery is to treat organs in the chest or thorax that are diseased or damaged.
The pandemic has triggered unprecedented increased demand for certain medical devices while significant disruption to manufacturing and supply chain of various others. The pandemic forced various countries to go into lockdown which also disrupted the supply chain of several raw materials and components for certain surgical medical devices including the devices used for thoracic surgeries.
However, the launch of new products and new acquisitions by the companies intend to increase the supply of the thoracic surgery devices market.
The complications of the virus reach well beyond respiratory failure to life-threatening cardiac, renal and immunological dysfunction to name a few. The consequences have been profound for cardiac surgery and cardiac surgeons. Although they are not as involved as the front-line warriors, they have been called upon to provide the local healthcare providers who have navigated the various challenges posed by the virus with leadership and direction. Due to their engagement in the prevention of the on-going pandemic, the demand for the thoracic surgery devices were reduced. Though, the growing demand for cardiovascular surgeries which are driven by factors which include the increase in the cardiac rhythm management (CRM) system replacements, the increasing number of CRM implantation facilities and also the rising popularity of CVD and lung diseases.
COVID-19 has created havoc causing drastic changes in the healthcare sector. However, due to the new law added by the CARES Act, the thoracic surgery devices market had come to a halt. But the thoracic surgery devices market is expected to boom in the coming years majorly due to the increase in cardiovascular surgeries, high prevalence of lung diseases and rise in the number of people opting for VATS.